ACELYRIN Completes Merger and Delists from Nasdaq

ACELYRIN, INC. ( (SLRN) ) has shared an announcement.

On May 21, 2025, ACELYRIN, Inc. completed a merger with Alumis, becoming a wholly owned subsidiary. Following the merger, ACELYRIN terminated its Employee Stock Purchase Plan, delisted its common stock from Nasdaq, and ceased its reporting obligations under the Securities Exchange Act. As a result of the merger, there was a change in control, with all directors and executive officers of ACELYRIN being replaced by those from the Merger Sub. Additionally, ACELYRIN’s certificate of incorporation and bylaws were amended to align with those of the Merger Sub.

The most recent analyst rating on (SLRN) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on ACELYRIN, INC. stock, see the SLRN Stock Forecast page.

Spark’s Take on SLRN Stock

According to Spark, TipRanks’ AI Analyst, SLRN is a Underperform.

SLRN faces significant financial challenges with no current revenue generation and reliance on external financing. However, the announced merger with Alumis Inc. is a positive strategic development that may improve future prospects. Technical indicators are mixed, and the company’s valuation metrics are unattractive due to ongoing losses. Investors should be cautious, considering the high risk associated with the company’s current financial situation.

To see Spark’s full report on SLRN stock, click here.

More about ACELYRIN, INC.

Average Trading Volume: 1,263,693

Technical Sentiment Signal: Sell

Current Market Cap: $225.1M

For a thorough assessment of SLRN stock, go to TipRanks’ Stock Analysis page.